Evidence map›Paper›PMID 32670627›Full record

ArticleSouthern African journal of HIV medicine2020

Feasibility of implementing a novel behavioural smoking cessation intervention amongst human immunodeficiency virus-infected smokers in a resource-limited setting: A single-arm pilot trial.

Billy M Tsima, Precious Moedi, Joyce Maunge, Kitso Machangane, Martha Kgogwane, Tebogo Mudojwa, Joseph Bastian, Warren Bilker, Rebecca Ashare, Robert Schnoll and 1 more

Open access · goldAbstract read
In one paragraph

Article in Southern African journal of HIV medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Interventions for tobacco use cessation in people living with HIV.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. The role of alternative reinforcers in smoking outcomes among people with and without HIV.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2025
    Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Tobacco Use and Treatment of Tobacco Dependence Among People With Human Immunodeficiency Virus: A Practical Guide for Clinicians.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  10. Tobacco Use among HIV-Positive and HIV-Negative Women and Men in Zambia-Demographic and Health Survey, 2018.International journal of environmental research and public health · 2022
    Article
  11. Review
  12. Mental health research in Botswana: a semi-systematic scoping review.The Journal of international medical research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Billy M TsimaDepartment of Family Medicine and Public Health, Faculty of Medicine, University of Botswana, Gaborone, Botswana.ORCID https://orcid.org/0000-0002-8534-7198
Precious MoediPrincess Marina Hospital, Dental Department, Gaborone, Botswana.ORCID https://orcid.org/0000-0001-6724-6628
Joyce MaungeBotswana UPenn Partnership, Gaborone, Botswana.ORCID https://orcid.org/0000-0002-5149-275X
Kitso MachanganeBotswana UPenn Partnership, Gaborone, Botswana.ORCID https://orcid.org/0000-0001-6917-8171
Martha KgogwaneBotswana UPenn Partnership, Gaborone, Botswana.ORCID https://orcid.org/0000-0003-2839-4948
Tebogo MudojwaBotswana UPenn Partnership, Gaborone, Botswana.ORCID https://orcid.org/0000-0002-7120-775X
Joseph BastianDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America.ORCID https://orcid.org/0000-0002-6565-9581
Warren BilkerDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America.ORCID https://orcid.org/0000-0002-2704-7525
Rebecca AshareDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America.ORCID https://orcid.org/0000-0003-4664-009X
Robert SchnollDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America.ORCID https://orcid.org/0000-0002-4089-856X
Robert GrossDepartment of Medicine (ID), Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States of America.ORCID https://orcid.org/0000-0001-6066-1159
University of Pennsylvania · USPrincess Margaret Hospital · HKUniversity of Botswana · BW

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ronald G Collman · 1999 to 2026
$78.6M
Penn Mental Health AIDS Research CenterP30MH097488 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI Karine Dube, Kelly L Jordan-Sciutto · 2013 to 2026
$23.5M
NIAID NIH HHS P30 AI045008NIMH NIH HHS P30 MH097488
6 · The paper itself

Abstract

backgroundTobacco use is prevalent amongst individuals infected with human immunodeficiency virus (HIV). In resource-constrained settings, pharmacological smoking cessation interventions are unfeasible because of their high cost. There is a need to develop and evaluate behavioural interventions to address the unique challenges of tobacco use in the HIV-infected populations in these settings.

objectivesThe authors aimed to assess the feasibility and acceptability of the Behavioural Activation/Problem Solving for Smoking Cessation (BAPS-SC) intervention programme to determine whether it should be tested in an adequately powered randomised controlled trial.

methodThe authors merged behavioural activation therapy (BAT) with the principles of problem-solving therapy to create a novel five-session counselling model to address the unique challenges of tobacco cessation amongst those infected with HIV. Feasibility measures included the rate of enrolment amongst those eligible and the retention rate and descriptive analysis of intervention acceptability. The authors' secondary outcome was 7-day point smoking prevalence abstinence, confirmed with breath carbon monoxide.

resultsA total of 128 individuals were screened over 8 weeks with 50 deemed eligible and 40 enrolled (80%). Retention at week 12 was 53% (21/40). The 7-day point prevalence abstinence, co-confirmed, at week 12 was 37.5% (15/40). All respondents indicated that they would recommend BAPS-SC to other smokers who want to quit, and would be willing to participate in the programme again up to the point of exit if they did not stop smoking.

conclusionA full-scale randomised control trial comparing BAPS-SC with usual practice is warranted to evaluate the efficacy of this novel intervention in these settings.

Indexed as

behaviour activationHIVproblem solvingsmoking cessationtobacco

Identifiers

PMID32670627
PMCPMC7343953
OpenAlexW3037768267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.